Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration

Go back to Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration
(NASDAQ: RXRX) Delayed: 3.64 --0 (-0%)
Previous Close $3.64    52 Week High $ 
Open $3.64    52 Week Low $ 
Day High $3.64    P/E N/A 
Day Low $3.64    EPS $ 
Volume 585,448